glp-1 receptor agonist structure 2 | GCGR Agonist GLP-1 receptor agonist 11 |
Description
(), , trend or significant increment in this parameter (weak, intermediate, or strong effect)
GIP binds to the GIP receptor (GIPR) [13-15], which is expressed on the surface of pancreatic -cells, stimulating insulin secretion [16]
Heres how its different from previous meds: Retatrutide is a triple agonist, meaning it targets three different hormone receptors, rather than one (like Ozempic) or two (like Mounjaro or Zepbound)
doi: 10.1016/S2213-8587(24)00155-4
therefore, the use of real-world data can help to quantify the clinical effects of such a treatment change
